{
    "RADCURE-3348": {
        "question": "Age: 81.1, Sex: Male, ECOG PS: ECOG 0, Smoking PY: 50, Smoking Status: Current, Ds Site: Oropharynx, Subsite: Base of Tongue, T: T1, N: N2b, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: Negative, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: Yes, Regional: none, Distant: Yes, 2nd Ca: Y, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases and elderly patients. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, the base of the skull, the oropharynx, and the upper airway.\n- The spinal column is well visualized with normal alignment.\n- Soft tissue structures of the oropharynx and surrounding areas are visible.\n- The masked region of interest (ROI) is located anterior to the cervical spine, likely involving the oropharyngeal soft tissues.\n- The ROI appears to be a highlighted or segmented area, possibly indicating a tumor or pathological lesion.\n- No obvious gross bone destruction or large necrotic areas are seen in this view.\n- The airway appears patent without significant obstruction.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates are given as:\n\n1. [264, 219, 52, 264, 301, 134]\n2. [253, 151, 106, 253, 181, 121]\n\n- These coordinates define volumetric regions within the scan.\n- The first bounding box spans a larger volume, likely encompassing a significant portion of the oropharyngeal region or adjacent lymph node areas.\n- The second bounding box is smaller and more localized, possibly representing a smaller lymph node or a subregion of the tumor.\n- Both bounding boxes are located in the mid to lower cervical region, consistent with the oropharynx and regional lymphatic drainage areas.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is an elderly male (81.1 years) with a history of heavy smoking (50 pack-years) and current smoking status, which negatively impacts prognosis.\n- The primary tumor site is the oropharynx, specifically the base of tongue, which is a common site for HPV-related squamous cell carcinoma but this patient is HPV negative, which generally confers a worse prognosis.\n- Tumor staging is T1 (small primary tumor), but with N2b nodal involvement (multiple ipsilateral lymph nodes), indicating regional spread.\n- No distant metastasis (M0) but stage IVA disease due to nodal involvement.\n- Treatment modality is radiation therapy alone, without chemotherapy, which may be suboptimal for this stage and HPV-negative status.\n- Dose of 70 Gy in 35 fractions is standard curative intent radiation dose.\n- Local control is achieved, but no regional or distant control is noted, and there is a second cancer present, which complicates prognosis.\n- ECOG performance status is 0, indicating good functional status, which is favorable.\n- The presence of a second cancer and ongoing smoking increase risk of mortality.\n- Overall, the prognosis is guarded due to HPV negativity, nodal disease, and second cancer, despite good performance status and adequate radiation dose.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a small primary tumor in the oropharynx with regional nodal involvement.\n- The masked ROI corresponds to the primary tumor or involved lymph nodes.\n- Bounding boxes likely delineate the tumor and involved lymph nodes.\n- Clinical factors including HPV negativity, heavy smoking, nodal disease, and second cancer worsen prognosis.\n- Treatment with radiation alone may be less effective in this context.\n- Despite good performance status, the patient's survival probability is reduced due to these adverse factors.\n\n('Answer:Dead',)",
        "Round 1-role-comment": "radiation oncologist:dead",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes. A medical oncologist is needed to provide expertise on systemic therapy options, especially given the HPV-negative status, nodal involvement, and presence of a second cancer, which may influence chemotherapy decisions and overall treatment planning. Additionally, a head and neck surgeon or diagnostic radiologist could be helpful for further evaluation of the tumor extent and nodal disease if surgical options or detailed imaging interpretation are required.",
        "Round 2-Turn 1-gap_identified-assistant": "- Consult a medical oncologist for expertise on systemic therapy options, particularly given the HPV-negative status, nodal involvement, and presence of a second cancer, which may influence chemotherapy decisions and overall treatment planning.  \n- Consult a head and neck surgeon for further evaluation of tumor extent and nodal disease if surgical options are being considered.  \n- Consult a diagnostic radiologist for detailed imaging interpretation to assess tumor extent and nodal disease.",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers, especially in HPV-negative cases with nodal involvement and second primary cancers. - Hierarchy: Medical Oncologist == Radiation Oncologist\n2. Head and Neck Surgeon - Your expertise is strictly limited to surgical evaluation and management of oropharyngeal squamous cell carcinoma, including assessment of tumor extent and nodal disease in elderly patients. - Hierarchy: Head and Neck Surgeon == Radiation Oncologist\n3. Diagnostic Radiologist - Your expertise is strictly limited to detailed imaging interpretation of head and neck cancers, including assessment of tumor extent, nodal involvement, and detection of second primary cancers using contrast-enhanced studies. - Hierarchy: Diagnostic Radiologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The image is a sagittal CT scan of the head and neck region.\n- Anatomical landmarks visible include the cervical vertebrae, base of the skull, oropharynx, and upper airway.\n- The spinal column shows normal alignment without obvious deformity.\n- Soft tissue structures of the oropharynx and surrounding areas are visible.\n- The masked region of interest (ROI) is located anterior to the cervical spine, in the oropharyngeal soft tissues, likely corresponding to a tumor or pathological lesion.\n- The ROI appears well-demarcated and is highlighted, suggesting segmentation of a lesion.\n- No gross bone destruction or large necrotic areas are apparent.\n- The airway is patent without significant obstruction.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates:\n\n1. [264, 219, 52, 264, 301, 134]\n2. [253, 151, 106, 253, 181, 121]\n\n- These define volumetric regions within the scan.\n- The first bounding box covers a larger volume, likely encompassing the primary tumor in the oropharynx and possibly adjacent lymph nodes.\n- The second bounding box is smaller and more localized, possibly representing a smaller lymph node or a subregion of the tumor.\n- Both bounding boxes are situated in the mid to lower cervical region, consistent with the oropharynx and regional lymphatic drainage.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is an elderly male (81.1 years) with a heavy smoking history (50 pack-years) and current smoking status, which negatively impacts prognosis.\n- Primary tumor site is the oropharynx, base of tongue, a common site for HPV-related squamous cell carcinoma; however, this patient is HPV negative, which generally confers a worse prognosis.\n- Tumor staging is T1 (small primary tumor) with N2b nodal involvement (multiple ipsilateral lymph nodes), indicating regional spread.\n- No distant metastasis (M0) but stage IVA disease due to nodal involvement.\n- Treatment was radiation therapy alone (70 Gy in 35 fractions), without chemotherapy, which may be suboptimal for this stage and HPV-negative status.\n- Local control is achieved, but regional control is lacking, and distant metastasis is present.\n- Presence of a second cancer further complicates prognosis.\n- ECOG performance status is 0, indicating good functional status, which is favorable.\n- Overall prognosis is guarded to poor due to HPV negativity, nodal disease, distant metastasis, second cancer, and ongoing smoking.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a small primary tumor in the oropharynx with regional nodal involvement.\n- The masked ROI corresponds to the primary tumor or involved lymph nodes.\n- Bounding boxes delineate the tumor and involved lymph nodes.\n- Clinical factors including HPV negativity, heavy smoking, nodal disease, distant metastasis, and second cancer worsen prognosis.\n- Treatment with radiation alone may be insufficient in this context.\n- Despite good performance status, the patient's survival probability is significantly reduced due to these adverse factors.\n\n('Answer:Dead',)",
        "Round 2-Turn 1-gap_recruited_assessment-head and neck surgeon": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Anatomical structures visible include the cervical vertebrae, base of the skull, oropharynx, and upper airway.\n- The spinal column shows normal alignment without obvious deformity.\n- Soft tissue structures of the oropharynx and surrounding areas are visible.\n- The masked region of interest (ROI) is located anterior to the cervical spine, within the oropharyngeal soft tissues.\n- The ROI appears as a highlighted area, likely representing a tumor or pathological lesion.\n- No gross bone destruction or large necrotic areas are evident.\n- The airway appears patent without significant obstruction.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates:\n\n1. [264, 219, 52, 264, 301, 134]\n2. [253, 151, 106, 253, 181, 121]\n\n- These coordinates define two volumetric regions within the scan.\n- The first bounding box covers a larger volume, likely encompassing the primary tumor in the oropharynx or adjacent lymph node regions.\n- The second bounding box is smaller and more localized, possibly representing a smaller lymph node or a subregion of the tumor.\n- Both bounding boxes are situated in the mid to lower cervical region, consistent with the oropharynx and regional lymphatic drainage areas.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is an elderly male (81.1 years) with a significant smoking history (50 pack-years) and current smoking status, which negatively impacts prognosis.\n- Primary tumor site is the oropharynx, specifically the base of tongue.\n- Tumor staging is T1 (small primary tumor), but with N2b nodal involvement (multiple ipsilateral lymph nodes), indicating regional spread.\n- No distant metastasis (M0), but stage IVA disease due to nodal involvement.\n- Treatment modality is radiation therapy alone, without chemotherapy, which may be suboptimal for this stage and HPV-negative status.\n- Radiation dose of 70 Gy in 35 fractions is standard curative intent.\n- Local control is achieved, but no regional or distant control is noted, and there is a second cancer present, complicating prognosis.\n- ECOG performance status is 0, indicating good functional status, which is favorable.\n- The presence of a second cancer and ongoing smoking increase mortality risk.\n- Overall prognosis is guarded due to HPV negativity, nodal disease, and second cancer, despite good performance status and adequate radiation dose.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a small primary tumor in the oropharynx with regional nodal involvement.\n- The masked ROI corresponds to the primary tumor or involved lymph nodes.\n- Bounding boxes delineate the tumor and involved lymph nodes.\n- Clinical factors including HPV negativity, heavy smoking, nodal disease, and second cancer worsen prognosis.\n- Treatment with radiation alone may be less effective in this context.\n- Despite good performance status, the patient's survival probability is reduced due to these adverse factors.\n\n('Answer:Dead',)",
        "Round 2-Turn 1-gap_recruited_assessment-diagnostic radiologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The image is a sagittal contrast-enhanced CT scan of the head and neck.\n- Anatomical structures visible include the cervical vertebrae, base of the skull, oropharynx, nasopharynx, and upper airway.\n- The spinal column shows normal alignment without evidence of fracture or destructive bone lesions.\n- Soft tissues of the oropharynx and hypopharynx are visualized.\n- The airway lumen appears patent without significant narrowing or obstruction.\n- The masked region of interest (ROI) is located anterior to the cervical spine, in the oropharyngeal region, likely involving soft tissues of the base of tongue or adjacent structures.\n- The ROI is well-demarcated and appears hyperdense relative to surrounding soft tissues, consistent with a contrast-enhancing lesion, likely a tumor.\n- No gross necrosis or cystic changes are evident within the ROI.\n- No obvious large lymphadenopathy is seen in this sagittal slice, but this view is limited for nodal assessment.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates:\n\n1. [264, 219, 52, 264, 301, 134]\n2. [253, 151, 106, 253, 181, 121]\n\n- These coordinates correspond to volumetric regions within the 3D CT volume.\n- The first bounding box is larger and likely encompasses the primary tumor in the oropharynx, possibly including adjacent soft tissue and regional lymph nodes.\n- The second bounding box is smaller and more localized, likely representing a single involved lymph node or a subregion of the tumor.\n- Both bounding boxes are situated in the mid to lower cervical region, consistent with the oropharynx and regional nodal basins.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is an elderly male (81.1 years) with a significant smoking history (50 pack-years) and current smoking status, which negatively impacts prognosis.\n- Primary tumor site is the oropharynx, specifically the base of tongue, a common site for squamous cell carcinoma.\n- Tumor staging is T1 (small primary tumor), but with N2b nodal involvement (multiple ipsilateral lymph nodes), indicating regional spread.\n- No distant metastasis (M0) but stage IVA disease due to nodal involvement.\n- HPV-negative status is associated with worse prognosis compared to HPV-positive oropharyngeal cancers.\n- Treatment was radiation therapy alone (70 Gy in 35 fractions) without chemotherapy, which may be suboptimal for this stage and HPV-negative status.\n- Local control is achieved, but there is no regional control and distant metastasis is present.\n- Presence of a second primary cancer further complicates prognosis.\n- ECOG performance status is 0, indicating good functional status, which is favorable.\n- Overall, the prognosis is guarded to poor due to HPV negativity, nodal disease, distant metastasis, second cancer, and ongoing smoking.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a small primary tumor in the oropharynx with regional nodal involvement.\n- The masked ROI corresponds to the primary tumor or involved lymph nodes.\n- Bounding boxes delineate the tumor and involved lymph nodes.\n- Clinical factors including HPV negativity, heavy smoking, nodal disease, distant metastasis, and second cancer worsen prognosis.\n- Treatment with radiation alone may be less effective in this context.\n- Despite good performance status, the patient's survival probability is significantly reduced due to these adverse factors.\n\n('Answer:Dead',)",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-medical oncologist": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-head and neck surgeon": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-diagnostic radiologist": "No",
        "Round 2-role-comment": "radiation oncologist:dead|medical oncologist:dead|head and neck surgeon:dead|diagnostic radiologist:dead",
        "Round 2-num_agents": 4,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Dead',)"
    }
}